Meeder Asset Management Inc. Acquires 2,165 Shares of Encompass Health Co. (NYSE:EHC)

Meeder Asset Management Inc. increased its holdings in shares of Encompass Health Co. (NYSE:EHC) by 3.3% in the fourth quarter, Holdings Channel.com reports. The firm owned 68,570 shares of the company’s stock after purchasing an additional 2,165 shares during the quarter. Meeder Asset Management Inc.’s holdings in Encompass Health were worth $6,332,000 as of its most recent SEC filing.

Other hedge funds have also recently bought and sold shares of the company. MassMutual Private Wealth & Trust FSB boosted its stake in Encompass Health by 87.8% in the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 293 shares of the company’s stock worth $27,000 after purchasing an additional 137 shares during the period. CBIZ Investment Advisory Services LLC grew its holdings in shares of Encompass Health by 38.7% during the fourth quarter. CBIZ Investment Advisory Services LLC now owns 455 shares of the company’s stock worth $42,000 after buying an additional 127 shares in the last quarter. Tompkins Financial Corp acquired a new stake in Encompass Health in the 4th quarter valued at approximately $46,000. V Square Quantitative Management LLC lifted its stake in Encompass Health by 43.8% in the 4th quarter. V Square Quantitative Management LLC now owns 581 shares of the company’s stock valued at $54,000 after acquiring an additional 177 shares in the last quarter. Finally, Morse Asset Management Inc bought a new position in shares of Encompass Health during the 3rd quarter worth approximately $68,000. 97.25% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In other Encompass Health news, CAO Andrew L. Price sold 5,042 shares of the stock in a transaction on Thursday, February 13th. The stock was sold at an average price of $98.29, for a total transaction of $495,578.18. Following the transaction, the chief accounting officer now owns 69,164 shares in the company, valued at $6,798,129.56. This trade represents a 6.79 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 2.10% of the stock is currently owned by insiders.

Analyst Ratings Changes

A number of brokerages have recently commented on EHC. KeyCorp boosted their price objective on shares of Encompass Health from $117.00 to $120.00 and gave the stock an “overweight” rating in a research report on Monday, February 10th. Barclays increased their price objective on shares of Encompass Health from $116.00 to $118.00 and gave the stock an “overweight” rating in a research note on Friday, February 7th. William Blair reaffirmed an “outperform” rating on shares of Encompass Health in a research report on Friday, February 7th. Royal Bank of Canada reissued an “outperform” rating and set a $110.00 price target on shares of Encompass Health in a research report on Tuesday, February 11th. Finally, StockNews.com upgraded Encompass Health from a “hold” rating to a “buy” rating in a research note on Saturday, February 15th. Ten equities research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat, the company has an average rating of “Buy” and an average price target of $107.67.

Encompass Health Stock Down 0.4 %

EHC opened at $100.75 on Monday. The company has a current ratio of 1.05, a quick ratio of 1.04 and a debt-to-equity ratio of 0.84. The stock’s fifty day simple moving average is $98.67 and its 200 day simple moving average is $97.46. Encompass Health Co. has a 1-year low of $78.53 and a 1-year high of $111.00. The stock has a market cap of $10.15 billion, a PE ratio of 22.59, a price-to-earnings-growth ratio of 2.31 and a beta of 0.92.

Encompass Health (NYSE:EHC) last posted its earnings results on Thursday, February 6th. The company reported $1.17 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.05 by $0.12. Encompass Health had a net margin of 8.48% and a return on equity of 17.56%. As a group, research analysts expect that Encompass Health Co. will post 4.8 earnings per share for the current year.

Encompass Health Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, April 15th. Stockholders of record on Tuesday, April 1st will be paid a dividend of $0.17 per share. The ex-dividend date of this dividend is Tuesday, April 1st. This represents a $0.68 dividend on an annualized basis and a dividend yield of 0.67%. Encompass Health’s dividend payout ratio (DPR) is currently 15.25%.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.